Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acromegaly.php on line 2
Acromegaly
LE WE PMID CA
Acromegaly80Akromegalie

Acromegaly

Cardiovascular risk

Cushing s syndrome

Pegvisomant

Somatostatin analogs

2000  
1
Modern approaches to treating acromegaly.
[10623775] QJM 93(1): 1-6 (2000)
2000  
2
Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.
[10911548] Clin Invest Med 23(3): 172-87 (2000)
2009  
3
Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation.
[19814797] BMC Endocr Disord 9(): 20 (2009)
2010  
4
Acromegaly: a review of current medical therapy and new drugs on the horizon.
[20887125] Neurosurg Focus 29(4): E15 (2010)
2010  
5
Pharmacological management of acromegaly: a current perspective.
[20887124] Neurosurg Focus 29(4): E14 (2010)
2010  
6
Radiation treatment strategies for acromegaly.
[20887122] Neurosurg Focus 29(4): E12 (2010)
2010  
7
The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas.
[20887121] Neurosurg Focus 29(4): E11 (2010)
2004  
8
Pharmacological approach to the treatment of acromegaly.
[15191332] Neurosurg Focus 16(4): E3 (2004)
2004  
9
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
[14769829] Endocr Rev 25(1): 102-52 (2004)
2005  
10
Simple detection of trace Pb2+ by enrichment on cerium phosphate membrane filter coupled with color signaling.
[16222377] Analyst 130(11): 1537-42 (2005)
1962  
11
Acromegaly: a review of 100 cases.
[13949186] Can Med Assoc J 87(-): 1106-9 (1962)
2008  
12
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
[18524797] Eur J Endocrinol 159(2): 89-95 (2008)
2003  
13
Pegvisomant: an advance in clinical efficacy in acromegaly.
[12670298] Eur J Endocrinol 148 Suppl 2(): S27-32 (2003)
1997  
14
Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature.
[9192949] Eur Respir J 10(6): 1401-4 (1997)
2008  
15
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly.
[18477663] J Clin Endocrinol Metab 93(8): 2957-68 (2008)
2008  
16
Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
[18390816] J Clin Endocrinol Metab 93(4): 1181-2 (2008)
2008  
17
Mortality in acromegaly: a metaanalysis.
[17971431] J Clin Endocrinol Metab 93(1): 61-7 (2008)
2007  
18
Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.
[17311857] J Clin Endocrinol Metab 92(5): 1743-7 (2007)
2005  
19
Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.
[15886238] J Clin Endocrinol Metab 90(8): 4465-73 (2005)
2005  
20
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly.
[15613435] J Clin Endocrinol Metab 90(3): 1856-63 (2005)
2004  
21
Monitoring the response to treatment in acromegaly.
[15531471] J Clin Endocrinol Metab 89(11): 5289-91 (2004)
2003  
22
Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.
[12629068] J Clin Endocrinol Metab 88(3): 963-8 (2003)
2002  
23
Guidelines for acromegaly management.
[12213843] J Clin Endocrinol Metab 87(9): 4054-8 (2002)
2002  
24
1998  
25
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.
[9768641] J Clin Endocrinol Metab 83(10): 3419-26 (1998)
2009  
26
Acromegaly pathogenesis and treatment.
[19884662] J Clin Invest 119(11): 3189-202 (2009)
2008  
27
2003  
28
1996  
29
Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.
[8745396] Protein Sci 5(2): 195-203 (1996)
1987  
30
Acromegaly update--etiology, diagnosis and management.
[3554758] West J Med 146(3): 328-36 (1987)
2008  
31
Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.
[18567075] World J Gastroenterol 14(22): 3484-9 (2008)
1996  
32
The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey.
[8709926] Neurotoxicol Teratol 18(2): 147-54 (1996)
2010  
33
A consensus on criteria for cure of acromegaly.
[20410227] J Clin Endocrinol Metab 95(7): 3141-8 (2010)
2010  
34
Approach to the patient with persistent acromegaly after pituitary surgery.
[20823464] J Clin Endocrinol Metab 95(9): 4114-23 (2010)
2010  
35
Acromegaly without imaging evidence of pituitary adenoma.
[20610592] J Clin Endocrinol Metab 95(9): 4192-6 (2010)
2008  
36
2011  
37
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.
[21846616] Endocr Pract 17 Suppl 4(-): 1-44 (2011)
2010  
38
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.
[19473180] Clin Endocrinol (Oxf) 72(2): 203-8 (2010)
2010  
39
Mortality in patients with pituitary disease.
[20086217] Endocr Rev 31(3): 301-42 (2010)
2005  
40
Etiologic aspects and management of acromegaly.
[16444346] Arq Bras Endocrinol Metabol 49(5): 626-40 (2005)
2008  
41
Somatostatin agonists for treatment of acromegaly.
[18191325] Mol Cell Endocrinol 286(1-2): 192-8 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acromegaly.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Acromegaly.php on line 92